Structure Therapeutics (GPCR) Treasury Shares (2022 - 2025)

Structure Therapeutics' Treasury Shares history runs 4 years deep, the most recent figure standing at $4.3 million for Q4 2025.

• On a quarterly basis, Treasury Shares rose 308.37% year-over-year to $4.3 million in Q4 2025; TTM through Dec 2025 was $4.3 million, a 308.37% increase from a year earlier, with the FY2025 full-year figure at $4.3 million, up 308.37% from the prior year.
• Treasury Shares advanced to $4.3 million in Q4 2025 per GPCR's latest filing, from $1.1 million in the prior quarter.
• Across five years, Treasury Shares topped out at $32.9 million in Q2 2022 and bottomed at $945.0 in Q1 2024.
• The 4-year median for Treasury Shares is $1.1 million (2024), against an average of $11.3 million.
• Across the five-year window, Treasury Shares sank 99.57% in 2023 and soared 308.37% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $32.9 million in 2022, then slumped by 99.0% to $327000.0 in 2023, then surged by 221.41% to $1.1 million in 2024, then surged by 308.37% to $4.3 million in 2025.
• Per Business Quant, the three latest GPCR Treasury Shares figures stand at $4.3 million (Q4 2025), $1.1 million (Q4 2024), and $1.1 million (Q3 2024).